Tradestie Institutional Equity Comparison Engine

PTN vs ENTX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ENTX Overall Edge

ENTX Captures Institutional Edge (3โ€“1 Pillars ยท 7โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Entera Bio Ltd. Ordinary Shares (ENTX) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while PTN counters with relative strength in Valuation. Fundamentally, PTN trades at 42.9x Forward P/E with -65.7% operating margin (-80.1% YoY revenue) versus ENTX at N/M Forward P/E and 0.0% operating margin (-100.0% YoY). In options structure, PTN sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ENTX sits in CONSOLIDATION (32nd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner PTN
PTN 42.9x vs ENTX N/M Fwd P/E
Growth & Margin Winner ENTX
Op Margin -65.7% vs 0.0% ยท YoY -80.1% vs -100.0%
Momentum & Technical Winner ENTX
1Y -43.3% vs +10.2% ยท 52W Pos 6% vs 64%
Options & Structure Winner ENTX
UNCLASSIFIED (N/A IV) vs CONSOLIDATION (32nd %ile IV)
PTN US Equity
Palatin Technologies, Inc.
Pharmaceutical Preparations
$6.12
-1.69% 1D
Market Cap $11.1M
1M Return +1.74%
1Y Return -43.29%
Forward P/E 42.9x
Unified AI Score
31.5 / 100 SELL
Tech 15.0 Fund 30.0 Flow 50.0 Mom 40.0
ENTX NASDAQ
Entera Bio Ltd. Ordinary Shares
Biological Products, (No Disgnostic Substances)
$3.02
-2.89% 1D
Market Cap $541.6M
1M Return +12.69%
1Y Return +10.22%
Forward P/E N/M
Unified AI Score
53.5 / 100 HOLD
Tech 35.0 Fund 55.0 Flow 72.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: PTN -43.29% ENTX +10.22% Spread: +53.51 pp (ENTX Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period PTN Revenue ENTX Revenue PTN Op. Margin ENTX Op. Margin Margin Edge
FY2019 $60M N/A 59.3% N/A PTN
FY2020 $0M $0M -20007.6% -3059.7% ENTX
FY2021 N/A $0M N/A -2139.6% ENTX
FY2022 $0M $0M -2491.6% -9714.2% PTN
FY2023 $0M N/A -668.7% N/A PTN
FY2024 $0M $0M -501.0% -5295.6% PTN
FY2025 N/A $0M N/A -27450.0% ENTX
FY2026 $10M N/A -65.7% N/A PTN

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: PTN (3) vs ENTX (7)
Institutional Metric PTN ENTX Criterion Row Winner
Market Capitalization Scale $11.1M $541.6M Larger Scale ENTX
Trailing P/E Ratio Valuation 42.9x N/M Lower Multiple PTN
Forward P/E Ratio Valuation 42.9x N/M Lower Multiple PTN
Revenue Growth (YoY) Growth -80.1% -100.0% Higher Growth PTN
Operating Margin (TTM) Profitability -65.7% 0.0% Higher Margin ENTX
Net Profit Margin Profitability -63.5% 0.0% Higher Margin ENTX
Return on Equity (ROE) Capital Efficiency -877.5% -20.3% Higher ROE ENTX
52-Week Range Position Momentum 6% ($5โ€“$31) 64% ($1โ€“$4) Stronger Trend ENTX
Beta / 30D Volatility Risk Regime 0.87ฮฒ ยท 106% Vol 1.07ฮฒ ยท 46% Vol Lower Realized Risk ENTX
Unified Institutional Score Composite Signal 31.5 / 100 (SELL) 53.5 / 100 (HOLD) Higher Composite ENTX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full PTN vs ENTX Buy Guide
PTN UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live PTN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ENTX CONSOLIDATION
79d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 32nd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live ENTX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither PTN nor ENTX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.